Basta Steven L

CIK 00014173975 companiesFLORHAM PARK

SEC Profile

Transactions

Companies

Filings

CIK

0001417397

Recent Transactions

50 trades

Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-02-10+12,362→ 379,592 total
Tax Payment
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-02-10$12.82/sh−6,277→ 373,315 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-01-02+251,034→ 364,820 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2026-01-02+226,156→ 221,156 total
Tax Payment
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-12-17$15.36/sh−31,502→ 113,786 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-12-17+62,038→ 145,288 total
Exercise/Conversion
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-11-28+90,000→ 131,625 total
Exercise/Conversion
Phathom Pharmaceuticals, Inc.$PHAT
Performance Shares
2025-11-28−90,000→ 180,000 total
Tax Payment
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-11-28$15.62/sh−48,375→ 83,250 total
Exercise/Conversion
Phathom Pharmaceuticals, Inc.$PHAT
Performance Shares
2025-09-25−90,000→ 270,000 total
Tax Payment
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-09-25$11.66/sh−48,375→ 41,625 total
Exercise/Conversion
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-09-25+90,000→ 90,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2025-04-03+1,085,000→ 1,085,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Performance Shares
2025-04-03+360,000→ 360,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option (right to buy)
2024-12-12+20,000→ 20,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option (right to buy)
2024-01-01+20,000→ 20,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option (right to buy)
2023-12-13+20,000→ 20,000 total
Award
VIVEVE MEDICAL, INC.
Restricted Stock Unit
2023-01-03+72,000→ 72,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2022-08-10+20,500→ 20,500 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Purchase)
2022-01-04+48,000→ 48,000 total
Disposition to Issuer
VIVEVE MEDICAL, INC.
Common Stock
2021-12-15$1.41/sh−28→ 25 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2021-07-19+20,500→ 20,500 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Purchase)
2021-06-23+116,200→ 116,200 total
Award
VIVEVE MEDICAL, INC.
Restricted Stock Unit
2021-01-20+50,000→ 50,000 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Purchase)
2020-09-21+165,000→ 165,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-08-03+22,500→ 22,500 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-03+14,499→ 536,537 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option
2020-03-19+45,000→ 45,000 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-09+7,108→ 522,038 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11$1.83/sh+14,000→ 509,764 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Restricted Stock Units
2019-12-11−238,800→ 0 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Non-Qualified Stock Option
2019-12-11$1.83/sh−14,000→ 357,641 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Restricted Stock Units
2019-12-11−238,800→ 0 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11$4.52/sh−85,210→ 495,764 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11+238,800→ 580,974 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11$4.52/sh−85,210→ 495,764 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11+238,800→ 580,974 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Non-Qualified Stock Option
2019-12-11$1.83/sh−14,000→ 357,641 total
Exercise/Conversion
VYNE Therapeutics Inc.$VYNE
Common stock
2019-12-11$1.83/sh+14,000→ 509,764 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Buy)
2019-11-26+660,000→ 660,000 total
Award
VYNE Therapeutics Inc.$VYNE
Restricted Stock Units
2019-07-29+238,800→ 1,050,100 total
Award
VYNE Therapeutics Inc.$VYNE
Restricted Stock Units
2019-07-29+238,800→ 1,050,100 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Purchase)
2019-05-29+35,000→ 35,000 total
Award
VIVEVE MEDICAL, INC.
Common Stock
2019-04-01+24,199→ 24,199 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Option (Right to Purchase)
2019-01-15+35,000→ 35,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option
2018-12-10+141,900→ 141,900 total
Award
VIVEVE MEDICAL, INC.
Non-Qualified Stock Options
2018-09-13+70,000→ 70,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option
2018-05-03+212,850→ 669,400 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2016-11-21$7.84/sh+1,125→ 1,125 total
Tax Payment
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2016-11-21$8.59/sh−1,026→ 99 total

Companies

Recent Filings

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, 07932

View on SEC.gov